Skip to content
IPOandMore
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD ReviewNCD Analysis & Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search
Menu Close
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search

Gland Pharma IPO

  1. Home>
  2. Gland Pharma IPO

Gland Pharma IPO: Brokerage Reviews

  • Post author:[email protected]
  • Post published:November 11, 2020
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Gland Pharma IPO attempts to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated from…

Continue ReadingGland Pharma IPO: Brokerage Reviews

Gland Pharma IPO Review

  • Post author:[email protected]
  • Post published:November 9, 2020
  • Post category:Buyback Review
  • Post comments:0 Comments

Gland Pharma IPO happens to be one of the largest IPO in the Pharma space. Gland Pharma, which is controlled by Chinese pharma giant Shanghai Fosun Pharma, is all set…

Continue ReadingGland Pharma IPO Review

Archives

Categories

Copyright - WordPress Theme by OceanWP